Elastography detected solid organ stiffness increased in patients with acromegaly.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
entrez:
18
1
2019
pubmed:
18
1
2019
medline:
29
1
2019
Statut:
ppublish
Résumé
Elastography is a method to examine the increase in solid organs stiffness (SOS), and there is no data in the literature regarding to its use in patients with acromegaly. In this study, we aimed to investigate the change of SOS in patients with acromegaly and to determine the parameters closely related to SOS in same patient groups.We included 40 subjects with acromegaly and 40 healthy control subjects. In addition to routine renal, liver and thyroid ultrasonography (USG), SOS for 3 solid organs were measured by elastography. The participants of the study were divided into 3 groups as the control (Group-I), acromegaly patients with remission (Group-II), and acromegaly patients without remission (Group-III).Insulin growth factor-1 (IGF-1) level significantly increased from Group-I to Group-III. Glucose, creatinine, albuminuria, alkaline phosphatase, TSH, and growth factor levels were highest in Group-III and statistically significance was found only between Group-I and Group-III. Liver, kidney and thyroid size and echogenicity were increased from Group-I to Group-III. Liver and renal stiffness and thyroid gland strain ratio significantly increased from Group-I to Group-III and these parameters were statistically different between all groups. In linear regression analysis, IGF-1 levels were independent determinants of SOS.SOS values of acromegaly patients with active disease were significantly increased compared to both the control group and the acromegaly patients in remission phase. Serum IGF-1 levels were independently associated with SOS in these patients. SOS measurement should be part of a routine USG examination in patients with acromegaly, especially in patients during active disease.
Identifiants
pubmed: 30653179
doi: 10.1097/MD.0000000000014212
pii: 00005792-201901180-00094
pmc: PMC6370059
doi:
Substances chimiques
IGF1 protein, human
0
Insulin-Like Growth Factor I
67763-96-6
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14212Références
Gastroenterol Hepatol (N Y). 2012 Sep;8(9):605-7
pubmed: 23483859
J Clin Endocrinol Metab. 2014 Nov;99(11):3933-51
pubmed: 25356808
Metabolism. 1996 Jan;45(1):109-13
pubmed: 8544766
Pituitary. 2017 Feb;20(1):70-75
pubmed: 27631334
J Investig Med. 2015 Apr;63(4):605-12
pubmed: 25738649
Br J Radiol. 2014 Dec;87(1044):20140604
pubmed: 25315887
BMC Nephrol. 2015 Jul 31;16:119
pubmed: 26227484
Ther Clin Risk Manag. 2016 Nov 07;12:1615-1622
pubmed: 27853373
AJR Am J Roentgenol. 2015 Feb;204(2):324-9
pubmed: 25615754
Thyroid. 2013 Jun;23(6):734-40
pubmed: 23136893
J Clin Endocrinol Metab. 2008 Jan;93(1):61-7
pubmed: 17971431
J Clin Endocrinol Metab. 2009 Jun;94(6):1945-50
pubmed: 19336512
Med Ultrason. 2016 Mar;18(1):30-5
pubmed: 26962551
Eur J Endocrinol. 2010 Sep;163(3):479-87
pubmed: 20592128
Eur J Endocrinol. 2010 Jun;162(6):1035-42
pubmed: 20356933
Med Ultrason. 2014 Dec;16(4):309-14
pubmed: 25463883
Can Med Assoc J. 1962 Nov 24;87:1106-9
pubmed: 13949186
Endocr Rev. 1996 Oct;17(5):423-80
pubmed: 8897021
Endocr Rev. 2014 Apr;35(2):234-81
pubmed: 24423979
J Clin Endocrinol Metab. 1988 Nov;67(5):973-8
pubmed: 3053751
Ultrasound Med Biol. 1998 Nov;24(9):1419-35
pubmed: 10385964
J Clin Invest. 1966 Sep;45(9):1379-87
pubmed: 5919343